The global pharmaceutical caps and closures market sale is poised for robust growth, with forecasts indicating a 5.8% compound annual growth rate (CAGR) over the forecast period. Anticipated to reach a market size of US$ 2,541.5 million by 2023, the market is driven by increasing demand for pharmaceutical products, advancements in drug delivery systems, and a growing emphasis on product safety and integrity.
Key Market Drivers:
- Demand for Pharmaceutical Products: The escalating demand for pharmaceutical products is a primary driver of market growth. As healthcare needs evolve and medical advancements continue, the pharmaceutical industry experiences increasing demand for innovative drug formulations and packaging solutions.
- Advancements in Drug Delivery Systems: Ongoing advancements in drug delivery systems drive innovation in caps and closures technology. Manufacturers prioritize developing solutions that enhance drug stability, improve patient compliance, and ensure product safety throughout the supply chain.
- Focus on Product Safety and Integrity: Caps and closures play a critical role in maintaining the quality and shelf life of pharmaceuticals by preventing contamination and ensuring product security. With a growing emphasis on product safety and integrity, stakeholders in the pharmaceutical industry prioritize investing in robust packaging solutions.
- Regulatory Compliance and Patient Convenience: Stringent regulatory requirements and a focus on patient convenience propel innovations in cap and closure technologies. Manufacturers incorporate features such as tamper-evident seals and child-resistant closures to meet regulatory standards and enhance user experience.
Market Dynamics: In the pharmaceutical industry, closures are integral to the container-closure system, ensuring the integrity and sterility of pharmaceutical preparations. Known variously as bungs or stoppers, pharmaceutical closures play a vital role in the final packaging of pharmaceutical products, safeguarding their quality and efficacy.
The use of pharmaceutical caps and closures ensures parenteral pharmaceuticals’ sterility. These also avert the entrance of contamination upon the insertion of a needle into a vial. Packaging solutions safeguard the drug from physical damage and even from biological degradation.
Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-13237
Drugs sensitive to water, light, and sometimes proximity to another sensitive substance, require effective caps and closures solutions. Increasing cases of chronic disorders and increasing administration of drugs are fueling the demand for caps and closures in pharmaceuticals. Moreover, favorable government policies and accelerating healthcare infrastructure are also fueling the market growth.
Growing demand for packaging in the pharmaceutical industry to protect the drugs from any external influences is projected to spur market growth. Companies active in the industry are offering an array of packaging solutions that cater to the needs of the pharmaceutical and healthcare industry while complying with strict industry standards.
Top Highlights from the FMI’s Analysis:
- North America’s pharmaceutical caps and closures industry gained a 29.6% market share in 2022.
- The United States pharmaceutical caps and closures industry is expected to acquire more than 26.5% in 2023.
- Europe region procured a 27.8% market share in 2022. Germany’s pharmaceutical caps and closures industry obtained a 4.8% market share in the same year.
- The United Kingdom market is projected to expand at a CAGR of 7.3% in the coming decade.
- In Asia Pacific, China, and India are projected to expand at a CAGR of 8.3% and 6.8%, respectively, in the forecast period.
- Australia’s pharmaceutical caps and closures industry is anticipated to expand at a CAGR of 4.5% from 2023 to 2033.
- Japan’s pharmaceutical caps and closures industry acquired a 6.4% market share, globally.
- Based on product, screw caps, and closures are projected to constitute 46.96% of the global market.
- Based on functionality, tamper evident segment is predicted to form more than 64.06% of the global market.
- Under the material category, the plastics segment is anticipated to contribute 60% to the global market.
- Based on drug modality, small molecules (synthetic drugs) secured 59.4% of the global market in 2022.
- Based on therapeutic class, anticancer drugs acquired a share of 20.5% in 2022.
- Based on end users, the pharmaceutical & biotechnology companies segment gained 52.8% of the entire market in 2022.
Market Update: Key Innovations Taking Place in this Market:
- Silgan Holdings acquired the dispensing business of Albea, which is a packaging firm, in June 2020. The dispensing business distributes sprayers, pumps, and foam dispensing solutions to large consumer goods firms. The business is operational in Europe, Asia, North America, and South America.
- Berry Global Group obtained RPC Group in July 2020. This acquisition helped in the positioning of the company as the global leader in value-added protective solutions and a significant plastic packaging company. Furthermore, the company has widened its global footprint spanning 290 locations the world over.
Key Players:
- Berry Global Inc.
- Amcor Plc
- Aptar, Inc.
- Closure Systems International, Inc.
- O.Berk Company, LLC
- Bericap GmbH and Co KG
- UNITED CAPS
- CL Smith Company
- Georg MENSHEN GmbH & Co. KG
- WestRock Company
- West Pharmaceutical Services, Inc
Market by Categorization:
By Product Type:
- Screw Caps & Closure
- Snap Caps & Closure
- Push-Pull Caps & Closure
- Stopper & Seals
- Others
By Functionality:
- Child Resistant
- Tamper-evident
By Material type:
- Plastic
- Elastomer
- Metal
By availability:
- Prescription (Rx) Pharmaceuticals
- Over-the-Counter (OTC) Pharmaceuticals
By Drug Modality:
- Small Molecule (Synthetic Drugs)
- Biopharmaceuticals
By Therapeutic class:
- Anticancer Drugs
- Anti-infective Drugs
- Anti-viral Drugs
- Anti-bacterial Drugs
- Anti-fungal Drugs
- Others
- Cardiovascular Drugs
- Anti-inflammatory Drugs
- Analgesics Drugs
- Anti-diabetics
- Ophthalmic Drugs
- Neurological Drugs
- Others
Request Report Methodology:https://www.futuremarketinsights.com/request-report-methodology/rep-gb-13237
By End Users:
- Pharmaceutical & Biotechnology Companies
- Contract Manufacturing Organizations (CMO)
- Contract Research Organizations (CROs)
- Academic & Research Institutes
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube